- Home
- Recruiting Trials
Recruiting Trials
Research Area
Study Name
Basic Eligibility
Doctors Referral
Participant Enquiry
Cardiology
Research Area:
Cardiology
Heart Failure
Study Name:
SODIUM-HF
Basic Eligibility:
Age 18 or overConfirmed diagnosis of Heart Failure
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.Research Area:
Cardiology
Coronary Artery Lesions
Study Name:
DynamX Sirolimus (ELX-CL-1801)
Basic Eligibility:
Age 18 or overEvidence of myocardial ischemia
Acceptable candidate for coronary artery bypass surgery
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Middlemore Hospital.Research Area:
Cardiology
Acute Coronary Syndrome
Study Name:
AEGIS-II (CSL112_3001)
Basic Eligibility:
Type 1 Myocardial infarctionHave at least two coronary artery territories of disease > 50%
Be on treatment for Diabetes
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Middlemore Hospital.Diabetes
Research Area:
Diabetes
Type 2 Diabetes
Study Name:
Type 2 Diabetes
Basic Eligibility:
Aged between 18 & 80 years oldType 2 diabetes for at least 12 months
Taking Metformin and/or sulphonylures
No change in diabetes treatment within previous 3 months
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyGastroenterology
Research Area:
Gastroenterology
Crohn's Disease
Study Name:
RISA (M15-991)
Basic Eligibility:
Moderate to severe abdominal pain and/or daily unformed stool frequency >4Previous biologic failure or intolerance (e.g. to infliximab or Humira)
No ileostomy/colostomy
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyHaematology
Research Area:
Haematology
Mantle Cell Lymphoma
Study Name:
Acerta 308 (ACE-LY-308)
Basic Eligibility:
Age over 65 yearsDiagnosed Mantle Cell Lymphoma
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.Research Area:
Haematology
Follicular Lymphoma
Study Name:
FL212 (BGB-3111-212)
Basic Eligibility:
Age over 18 yearsDiagnosed Follicular Lymphoma
Doctors Referral:
Refer a Patient
Participant Enquiry:
Ask your doctor if this is right for you.Hepatology
Research Area:
Hepatology
Fatty Liver
Study Name:
AURORA (3152-301-002)
Basic Eligibility:
Aged 18 - 75 yearsDiagnosed with NASH or ‘Fatty Liver’
Do not have HIV, Cirrhosis, Hepatitis B or C
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
Hepatology
Chronic Hepatitis B
Study Name:
DCR-HBVS-101, GS-US-493-5342, VIR (VIR-2218), YP (YP39364)
Basic Eligibility:
Age 18 to 65Chronic Hepatitis B infection
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyLipidology
Research Area:
Lipidology
Hypertriglyceridemia
Study Name:
AROAPOC31001
Basic Eligibility:
Age 18 to 70History of high triglyceride levels (>3.38 mmol/L)
BMI between 19 to 40kg/m2
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyNeonatal
Research Area:
Neonatal
Neonatal care
Study Name:
ABC
Basic Eligibility:
Infants born at less than 31 weeksHas delayed cord clamping
Non regular rhythmic breathing
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible premature infants at delivery.Research Area:
Neonatal
Neonatal care
Study Name:
PAEAN
Basic Eligibility:
Infants born at or more than 35 weeks Indication of perinatal depression
Moderate to severe encephalopathy
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible premature infants at delivery.Otolaryngology (ENT)
Research Area:
Otolaryngology (ENT)
Chronic Sinusitis
Study Name:
LYR-210
Basic Eligibility:
Age over 18Meet diagnostic criteria for chronic sinusitis
Had at least two trials of medical treatments in the past (one of which must be intranasal corticosteroid sprays for at least 4 weeks)
No previous sinuplasty or endo-nasal surgery other than septoplasty or surgical manipulation to nasal turbinates
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyPaediatrics
Research Area:
Paediatrics
Viral Respiratory Disease
Study Name:
SHIVERS
Basic Eligibility:
Viral respiratory disease Acute presentation to Middlemore Emergency Department or Intensive care unit
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients with acute presentation at Middlemore Hospital.Research Area:
Paediatrics
Rheumatic Fever
Study Name:
Start
Basic Eligibility:
Aged between 5 - 14 years Newly diagnosed with Acute rheumatic fever
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Middlemore Hospital.Research Area:
Paediatrics
Acute Hypoxic Respiratory Failure
Study Name:
PARIS 2
Basic Eligibility:
Aged less than 5 years oldAcute hypoxic respiratory failure
Requiring hospital admission
Doctors Referral:
Refer a Patient
Participant Enquiry:
Trial for eligible patients currently an inpatient at Kidz First Hospital.Renal
Research Area:
Renal
End Stage Renal Disease
Study Name:
PDOPPS 2
Basic Eligibility:
Aged over 18 years Have end stage renal disease;
Receiving chronic, maintenance Peritoneal dialysis
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
Renal
Chronic Kidney Disease
Study Name:
Ascend ND 200808
Basic Eligibility:
Age 18 years or overHave Chronic Kidney Disease
Needing to start on or on erythropoiesis stimulating agents (ESA) replacement therapy
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyRespiratory
Research Area:
Respiratory
Bronchiectasis
Study Name:
PROMIS I (Z7224L01)
Basic Eligibility:
Age 18 or overHave Non-Cystic Fibrosis Bronchiectasis
Have pseudomonas aeruginosa
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyRheumatology
Research Area:
Rheumatology
Psoriatic Arthritis
Study Name:
KeePsAKE 1 (M16-011)
Basic Eligibility:
Age 18 or overPsoriatic Arthritis
Swollen and tender joints
Skin psoriasis
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualifyResearch Area:
Rheumatology
Giant Cell Arthritis
Study Name:
Select - GCA (M16-852)
Basic Eligibility:
Age 50 or overDiagnosed Giant Cell Arthritis
Headache, jaw pain, vision loss
Shoulder and/or hip pain
Doctors Referral:
Refer a Patient
Participant Enquiry:
See if you qualify